ERBB2 and breast carcinoma: They utilized STAR-FISH to evaluate the clinical influence of changes in intra-tumoral heterogeneity for HER2 (ERBB2) amplification and the PIK3CA mutation within HER2-positive breast cancer subjected to neoadjuvant therapy, thus obtaining detailed information of spatial distribution characteristics and cancer cells’ subpopulations.